875151-77-2

Upstream product

• 701-27-9 3-fluorobenzene-1-sulfonyl chloride 
• 38068-77-8 (S)-piperidine-2-carboxylic acid benzyl ester hydrochloride 

Downstream Products

• 875151-76-1 (S)-1-(3-(fluoro)benzenesulfonyl)-piperidine-2-carboxylic acid 
• 875151-78-3 (S)-2-{[(S)-1-(3-fluoro-benzenesulfonyl)-piperidine-2-carbonyl]-amino}-3-(4-hydroxy-phenyl)-propionic acid benzyl ester 
• 875151-80-7 (S)-2-{[(S)-1-(3-Fluoro-benzenesulfonyl)-piperidine-2-carbonyl]-amino}-3-(4-isopropoxy-phenyl)-propionic acid 
• 875151-82-9 (S)-2-{[(S)-1-(3-fluoro-benzenesulfonyl)-piperidine-2-carbonyl]-amino}-3-[4-(3-fluoro-propoxy)-phenyl]-propionic acid 
• 875151-15-8 (S)-1-(3-fluoro-benzenesulfonyl)-piperidine-2-carboxylic acid [(S)-2-(4-cyclopentyloxyphenyl)-1-methyl-1-(tetrahydro-pyran-4-ylcarbamoyl)-ethyl]-amide 

Relevant academic research and scientific papers

FKBP BINDING COMPOSITION AND PHARMACEUTICAL USE THEREOF

A composition for binding FKBP proteins is disclosed, along with a method of treating conditions associated with neuronal degeneration, wherein said composition comprises a compound of formula I, wherein, R, R1, R2, R3 and

FKBP BINDING COMPOSITION AND PHARMACEUTICAL USE THEREOF

A composition for binding FKBP proteins is disclosed, along with a method of treating conditions associated with neuronal degeneration, wherein said composition comprises a compound of Formula (I), wherein, R, R1, R2, R3 a